US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

23.68

-0.2900-1.21%

Volume:435.63K

Turnover:10.40M

Market Cap:2.96B

PE:109.93

High:24.11

Open:23.79

Low:23.68

Close:23.97

52wk High:31.77

52wk Low:15.13

Shares:125.07M

Float Shares:111.18M

Volume Ratio:0.30

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2154

EPS(LYR):-0.1269

ROE:15.86%

ROA:5.09%

PB:13.43

PE(LYR):-186.66

Loading ...

Overview Company News Filings

Arcutis’ Zoryve® (Roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines

THOMSON REUTERS

Arcutis Biotherapeutics announces annual shareholder meeting

Arcutis Biotherapeutics (ARQT) Gets a Buy from Mizuho Securities

Why Arcutis Biotherapeutics (ARQT) Is Up 10.9% After Positive Infant Atopic Dermatitis Trial Data And What's Next

Simply Wall St.

Arcutis director Howard G. Welgus disposes of common shares worth $0.2 million

Arcutis management to present at Needham Virtual Healthcare Conference fireside chat

How New Infant Atopic Dermatitis Data And sNDA Plans At Arcutis (ARQT) Have Changed Its Investment Story

Simply Wall St.

Arcutis Biotherapeutics presents new Phase 2 results on Zoryve cream

Arcutis says Phase 2 trial shows Zoryve cream improves infant atopic dermatitis

A Look At Arcutis Biotherapeutics (ARQT) Valuation After Recent Share Price Weakness

Simply Wall St.

Arcutis Biotherapeutics to present clinical data on ZORYVE at AAD Meeting

Arcutis to present new ZORYVE trial data at American Academy of Dermatology annual meeting

Arcutis Biotherapeutics announces publication on Phase 3 study of Zoryve cream

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data With Zoryve® (Roflumilast) Cream 0.05% for Treatment of Mild-to-Moderate Atopic Dermatitis in Children Ages 2–5 in Pediatric Dermatology

THOMSON REUTERS

Arcutis Launches First-in-Human ARQ-234 Trial, Expanding Its Atopic Dermatitis Pipeline

Jefferies Remains a Buy on Arcutis Biotherapeutics (ARQT)

Press Release: Arcutis Announces Promotion of Mas Matsuda to Executive Vice President and Chief Legal Officer to Support Next Phase of Growth

Arcutis (ARQT) Earnings Call Signals Scaled Growth

Arcutis Biotherapeutics Director Keith R Leonard Disposes of Common Shares

Arcutis first participant enrolled in Phase 1a/1b trial of ARQ-234-131

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ARQT/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARQT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQT\",,,,,undefined,":{"symbol":"ARQT","market":"US","secType":"STK","nameCN":"Arcutis Biotherapeutics Inc.","latestPrice":23.68,"timestamp":1788289647146,"preClose":23.97,"halted":0,"volume":435629,"delay":0,"changeRate":-0.012098456403838095,"floatShares":111176161,"shares":125073249,"eps":0.215414,"marketStatus":"Trading","change":-0.29,"latestTime":"09-01 15:07:32 EDT","open":23.79,"high":24.11,"low":23.675,"amount":10398000.285115,"amplitude":0.018148,"askPrice":23.69,"askSize":195,"bidPrice":23.67,"bidSize":382,"shortable":3,"etf":0,"ttmEps":0.215414,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1580446800000,"exchange":"NASDAQ","adjPreClose":23.97,"preHourTrading":{"tag":"盘前","latestPrice":23.85,"preClose":23.97,"latestTime":"09:04 EDT","volume":1700,"amount":40572.5298,"timestamp":1788267876642,"change":-0.12,"changeRate":-0.005006,"amplitude":0.0534},"postHourTrading":{"tag":"盘后","latestPrice":23.94,"preClose":23.97,"latestTime":"19:55 EDT","volume":51086,"amount":1224520.466456,"timestamp":1788220545285,"change":-0.03,"changeRate":-0.001252,"amplitude":0.001252},"volumeRatio":0.300613,"impliedVol":0.5923,"impliedVolPercentile":0.4722},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQT\",,,,,undefined,":{"symbol":"ARQT","floatShares":111176161,"roa":"5.09%","roe":"15.86%","lyrEps":-0.12686,"volumeRatio":0.300613,"shares":125073249,"dividePrice":0,"high":24.11,"amplitude":0.018148,"preClose":23.97,"low":23.675,"week52Low":15.13,"pbRate":"13.43","psRate":"6.38","week52High":31.77,"institutionHeld":0,"latestPrice":23.68,"committee":0.32409,"eps":0.215414,"divideRate":0,"volume":435629,"delay":0,"ttmEps":0.215414,"open":23.79,"prevYearClose":29.04,"prevWeekClose":23.78,"prevMonthClose":23.97,"prevQuarterClose":26.22,"fiveDayClose":24.86,"twentyDayClose":26.03,"sixtyDayClose":21.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARQT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"ARQT","fiscalQuarterEnding":"2026/06","expectedEps":0.09,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.11},{"market":"US","date":"2026-05-06","symbol":"ARQT","fiscalQuarterEnding":"2026/03","expectedEps":-0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2026-02-25","symbol":"ARQT","fiscalQuarterEnding":"2025/12","expectedEps":0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-10-28","symbol":"ARQT","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2025-08-06","symbol":"ARQT","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARQT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARQT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1753588800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARQT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARQT","date":"2026-08-31","current":109.92786,"percent":0.986168,"low":-1515.109218,"twenty":-18.956806,"median":-5.104331,"eighty":-2.741089,"high":118.859688,"avg":-80.09084,"sd":283.281798,"marketCap":2988954832},"quantilePoints":[{"date":"2021-09-03","current":-7.236946,"twenty":-19.276369,"median":-11.234005,"eighty":-9.46478,"marketCap":1087734731},{"date":"2021-09-10","current":-7.069811,"twenty":-19.240298,"median":-11.181362,"eighty":-9.371152,"marketCap":1062613837},{"date":"2021-09-17","current":-7.577902,"twenty":-19.176572,"median":-11.175871,"eighty":-9.262153,"marketCap":1138981356},{"date":"2021-09-24","current":-7.748379,"twenty":-18.991408,"median":-11.158719,"eighty":-9.211846,"marketCap":1164604669},{"date":"2021-10-01","current":-8.426948,"twenty":-18.862754,"median":-11.111307,"eighty":-9.10564,"marketCap":1266595500},{"date":"2021-10-08","current":-7.467593,"twenty":-18.790612,"median":-11.079463,"eighty":-8.987558,"marketCap":1122401566},{"date":"2021-10-15","current":-7.447536,"twenty":-18.504449,"median":-11.034733,"eighty":-8.896023,"marketCap":1119387058},{"date":"2021-10-22","current":-7.210205,"twenty":-18.242332,"median":-11.017566,"eighty":-8.820821,"marketCap":1083715388},{"date":"2021-10-29","current":-7.079839,"twenty":-18.165381,"median":-11.007935,"eighty":-8.754886,"marketCap":1064121091},{"date":"2021-11-05","current":-6.559128,"twenty":-18.076405,"median":-10.979417,"eighty":-8.692002,"marketCap":1109010879},{"date":"2021-11-12","current":-6.303308,"twenty":-18.01268,"median":-10.956178,"eighty":-8.521261,"marketCap":1065756940},{"date":"2021-11-19","current":-5.410909,"twenty":-17.90086,"median":-10.948897,"eighty":-8.393247,"marketCap":914871106},{"date":"2021-11-26","current":-4.958761,"twenty":-17.811884,"median":-10.868783,"eighty":-8.205598,"marketCap":838422284},{"date":"2021-12-03","current":-4.572055,"twenty":-17.754171,"median":-10.821143,"eighty":-8.128839,"marketCap":773038422},{"date":"2021-12-10","current":-4.554207,"twenty":-17.686838,"median":-10.761965,"eighty":-7.988352,"marketCap":770020706},{"date":"2021-12-17","current":-5.077747,"twenty":-17.648362,"median":-10.740982,"eighty":-7.959145,"marketCap":858540395},{"date":"2021-12-23","current":-5.979069,"twenty":-17.635136,"median":-10.714699,"eighty":-7.901858,"marketCap":1010935087},{"date":"2021-12-31","current":-6.169448,"twenty":-17.589446,"median":-10.693296,"eighty":-7.750385,"marketCap":1043124065},{"date":"2022-01-07","current":-5.550718,"twenty":-17.546161,"median":-10.643177,"eighty":-7.597958,"marketCap":938509887},{"date":"2022-01-14","current":-5.178886,"twenty":-17.48484,"median":-10.587041,"eighty":-7.559851,"marketCap":875640789},{"date":"2022-01-21","current":-4.580979,"twenty":-17.470412,"median":-10.567335,"eighty":-7.447536,"marketCap":774547281},{"date":"2022-01-28","current":-4.363828,"twenty":-17.4644,"median":-10.537841,"eighty":-7.387368,"marketCap":737831728},{"date":"2022-02-04","current":-4.405474,"twenty":-17.434341,"median":-10.449358,"eighty":-7.317171,"marketCap":744873067},{"date":"2022-02-11","current":-4.601801,"twenty":-17.428329,"median":-10.423257,"eighty":-7.280401,"marketCap":778067950},{"date":"2022-02-18","current":-4.753509,"twenty":-17.416305,"median":-10.40616,"eighty":-7.257002,"marketCap":803718542},{"date":"2022-02-25","current":-4.392122,"twenty":-17.401877,"median":-10.39037,"eighty":-7.236278,"marketCap":906340769},{"date":"2022-03-04","current":-4.099151,"twenty":-17.186653,"median":-10.384149,"eighty":-7.159812,"marketCap":845884464},{"date":"2022-03-11","current":-4.1138,"twenty":-17.104892,"median":-10.36521,"eighty":-7.079171,"marketCap":848907279},{"date":"2022-03-18","current":-4.13089,"twenty":-17.033282,"median":-10.35086,"eighty":-7.04307,"marketCap":852433897},{"date":"2022-03-25","current":-4.196808,"twenty":-17.017183,"median":-10.332332,"eighty":-6.947015,"marketCap":866036566},{"date":"2022-04-01","current":-4.965857,"twenty":-17.009437,"median":-10.282581,"eighty":-6.851199,"marketCap":1024734366},{"date":"2022-04-08","current":-5.153847,"twenty":-16.959406,"median":-10.265886,"eighty":-6.753772,"marketCap":1063527161},{"date":"2022-04-14","current":-5.134315,"twenty":-16.882454,"median":-10.227872,"eighty":-6.5859,"marketCap":1059496741},{"date":"2022-04-22","current":-5.028274,"twenty":-16.82474,"median":-10.168371,"eighty":-6.49195,"marketCap":1037614493},{"date":"2022-04-29","current":-5.030766,"twenty":-16.782657,"median":-10.158834,"eighty":-6.312232,"marketCap":1038128672},{"date":"2022-05-06","current":-4.251266,"twenty":-16.696086,"median":-10.12128,"eighty":-6.093891,"marketCap":997508482},{"date":"2022-05-13","current":-3.929134,"twenty":-16.623945,"median":-10.10466,"eighty":-6.000487,"marketCap":921924076},{"date":"2022-05-20","current":-4.527379,"twenty":-16.597493,"median":-10.032757,"eighty":-5.701236,"marketCap":1062295115},{"date":"2022-05-27","current":-4.599694,"twenty":-16.581861,"median":-9.947741,"eighty":-5.53644,"marketCap":1079263043},{"date":"2022-06-03","current":-4.647904,"twenty":-16.572243,"median":-9.937348,"eighty":-5.380167,"marketCap":1090574995},{"date":"2022-06-10","current":-4.623799,"twenty":-16.501303,"median":-9.901868,"eighty":-5.305352,"marketCap":1084919019},{"date":"2022-06-17","current":-4.634756,"twenty":-16.287281,"median":-9.834399,"eighty":-5.210156,"marketCap":1087489917},{"date":"2022-06-24","current":-4.516422,"twenty":-16.104521,"median":-9.823919,"eighty":-5.174012,"marketCap":1059724217},{"date":"2022-07-01","current":-4.761856,"twenty":-16.026367,"median":-9.798403,"eighty":-5.084178,"marketCap":1117312335},{"date":"2022-07-08","current":-5.588004,"twenty":-15.925369,"median":-9.746482,"eighty":-5.07328,"marketCap":1311158056},{"date":"2022-07-15","current":-5.303125,"twenty":-15.91623,"median":-9.719112,"eighty":-5.07328,"marketCap":1244314704},{"date":"2022-07-22","current":-4.715837,"twenty":-15.564658,"median":-9.592702,"eighty":-5.07328,"marketCap":1106514563},{"date":"2022-07-29","current":-5.316274,"twenty":-15.554693,"median":-9.568888,"eighty":-5.045026,"marketCap":1247399782},{"date":"2022-08-05","current":-5.095799,"twenty":-15.511653,"median":-9.54618,"eighty":-5.035749,"marketCap":1325091253},{"date":"2022-08-12","current":-5.81655,"twenty":-15.450433,"median":-9.529289,"eighty":-5.039076,"marketCap":1512512503},{"date":"2022-08-19","current":-5.943853,"twenty":-15.366267,"median":-9.471951,"eighty":-5.045026,"marketCap":1545615642},{"date":"2022-08-26","current":-5.661473,"twenty":-15.363261,"median":-9.450107,"eighty":-5.073125,"marketCap":1472186861},{"date":"2022-09-02","current":-5.580463,"twenty":-15.348232,"median":-9.341806,"eighty":-5.07328,"marketCap":1451121227},{"date":"2022-09-09","current":-4.728696,"twenty":-15.304946,"median":-9.300061,"eighty":-5.043836,"marketCap":1229631135},{"date":"2022-09-16","current":-4.131533,"twenty":-15.137599,"median":-9.254467,"eighty":-5.029962,"marketCap":1074347321},{"date":"2022-09-23","current":-4.210229,"twenty":-15.084695,"median":-9.210797,"eighty":-5.001449,"marketCap":1094811079},{"date":"2022-09-30","current":-4.423171,"twenty":-15.033047,"median":-9.163634,"eighty":-4.978112,"marketCap":1150183602},{"date":"2022-10-07","current":-4.430114,"twenty":-15.013454,"median":-9.022191,"eighty":-4.953727,"marketCap":1151989228},{"date":"2022-10-14","current":-4.314385,"twenty":-14.988121,"median":-8.988956,"eighty":-4.912951,"marketCap":1121895466},{"date":"2022-10-21","current":-4.045893,"twenty":-14.920281,"median":-8.934805,"eighty":-4.879762,"marketCap":1052077937},{"date":"2022-10-28","current":-4.050523,"twenty":-14.860357,"median":-8.887642,"eighty":-4.851696,"marketCap":1053281687},{"date":"2022-11-04","current":-4.161623,"twenty":-14.777107,"median":-8.838732,"eighty":-4.821023,"marketCap":1082171699},{"date":"2022-11-11","current":-3.74156,"twenty":-14.629216,"median":-8.782835,"eighty":-4.767826,"marketCap":1162745956},{"date":"2022-11-18","current":-3.669042,"twenty":-14.567894,"median":-8.753139,"eighty":-4.759458,"marketCap":1140209759},{"date":"2022-11-25","current":-3.522045,"twenty":-14.103561,"median":-8.70947,"eighty":-4.744509,"marketCap":1094528278},{"date":"2022-12-02","current":-3.431887,"twenty":-13.679557,"median":-8.692002,"eighty":-4.724743,"marketCap":1066510303},{"date":"2022-12-09","current":-3.331929,"twenty":-13.444532,"median":-8.527592,"eighty":-4.700106,"marketCap":1035446897},{"date":"2022-12-16","current":-3.128093,"twenty":-13.276622,"median":-8.473649,"eighty":-4.681644,"marketCap":972101910},{"date":"2022-12-23","current":-2.80274,"twenty":-13.191719,"median":-8.384936,"eighty":-4.645231,"marketCap":870993566},{"date":"2022-12-30","current":-2.900738,"twenty":-13.151671,"median":-8.26928,"eighty":-4.621309,"marketCap":901447886},{"date":"2023-01-06","current":-2.941897,"twenty":-13.122655,"median":-8.163986,"eighty":-4.611636,"marketCap":914238701},{"date":"2023-01-13","current":-2.767461,"twenty":-13.049801,"median":-8.133031,"eighty":-4.600115,"marketCap":860030010},{"date":"2023-01-20","current":-3.182972,"twenty":-12.934795,"median":-8.076242,"eighty":-4.582877,"marketCap":989156329},{"date":"2023-01-27","current":-3.245691,"twenty":-12.934795,"median":-7.989013,"eighty":-4.572055,"marketCap":1008647094},{"date":"2023-02-03","current":-3.26725,"twenty":-12.920029,"median":-7.979314,"eighty":-4.516422,"marketCap":1015347045},{"date":"2023-02-10","current":-3.26529,"twenty":-12.912646,"median":-7.948441,"eighty":-4.503274,"marketCap":1014737959},{"date":"2023-02-17","current":-3.326049,"twenty":-12.908955,"median":-7.895458,"eighty":-4.485789,"marketCap":1033619637},{"date":"2023-02-24","current":-3.069295,"twenty":-12.857317,"median":-7.868717,"eighty":-4.450483,"marketCap":953829318},{"date":"2023-03-03","current":-3.049652,"twenty":-12.680466,"median":-7.728323,"eighty":-4.437802,"marketCap":949838659},{"date":"2023-03-10","current":-2.37108,"twenty":-12.618808,"median":-7.63807,"eighty":-4.40667,"marketCap":738491922},{"date":"2023-03-17","current":-2.174961,"twenty":-12.471889,"median":-7.577902,"eighty":-4.38775,"marketCap":677409050},{"date":"2023-03-24","current":-2.006299,"twenty":-12.393193,"median":-7.557845,"eighty":-4.361038,"marketCap":624877780},{"date":"2023-03-31","current":-2.15731,"twenty":-12.352805,"median":-7.457565,"eighty":-4.339559,"marketCap":671911592},{"date":"2023-04-06","current":-2.174961,"twenty":-12.251639,"median":-7.439179,"eighty":-4.317081,"marketCap":677409050},{"date":"2023-04-14","current":-2.890796,"twenty":-12.149257,"median":-7.387368,"eighty":-4.302982,"marketCap":900361533},{"date":"2023-04-21","current":-2.64981,"twenty":-12.111967,"median":-7.345584,"eighty":-4.287073,"marketCap":825304589},{"date":"2023-04-28","current":-2.710884,"twenty":-12.051307,"median":-7.307143,"eighty":-4.275809,"marketCap":844326479},{"date":"2023-05-05","current":-2.852732,"twenty":-12.013412,"median":-7.285415,"eighty":-4.272631,"marketCap":888506353},{"date":"2023-05-12","current":-2.030776,"twenty":-11.989787,"median":-7.273716,"eighty":-4.23106,"marketCap":664538936},{"date":"2023-05-19","current":-1.773778,"twenty":-11.963634,"median":-7.253659,"eighty":-4.213006,"marketCap":580440564},{"date":"2023-05-26","current":-1.572938,"twenty":-11.945281,"median":-7.236946,"eighty":-4.158119,"marketCap":514718723},{"date":"2023-06-02","current":-1.435916,"twenty":-11.932286,"median":-7.210205,"eighty":-4.134311,"marketCap":469880457},{"date":"2023-06-09","current":-1.878891,"twenty":-11.908703,"median":-7.144392,"eighty":-4.110552,"marketCap":614837042},{"date":"2023-06-16","current":-1.918308,"twenty":-11.884629,"median":-7.103238,"eighty":-4.057929,"marketCap":627735722},{"date":"2023-06-23","current":-1.741869,"twenty":-11.848545,"median":-7.076497,"eighty":-4.026885,"marketCap":569998776},{"date":"2023-06-30","current":-1.563553,"twenty":-11.714996,"median":-7.05644,"eighty":-3.967314,"marketCap":511647609},{"date":"2023-07-07","current":-1.745623,"twenty":-11.642467,"median":-7.04307,"eighty":-3.925051,"marketCap":571227222},{"date":"2023-07-14","current":-1.762516,"twenty":-11.614497,"median":-6.969247,"eighty":-3.848691,"marketCap":576755227},{"date":"2023-07-21","current":-1.944587,"twenty":-11.599484,"median":-6.88262,"eighty":-3.826122,"marketCap":636334841},{"date":"2023-07-28","current":-1.877014,"twenty":-11.593683,"median":-6.849193,"eighty":-3.729016,"marketCap":614222820},{"date":"2023-08-04","current":-1.899538,"twenty":-11.588195,"median":-6.768968,"eighty":-3.661986,"marketCap":621593493},{"date":"2023-08-11","current":-1.729492,"twenty":-11.576596,"median":-6.672481,"eighty":-3.558108,"marketCap":572148915},{"date":"2023-08-18","current":-1.513306,"twenty":-11.543391,"median":-6.559128,"eighty":-3.396999,"marketCap":500630301},{"date":"2023-08-25","current":-1.397758,"twenty":-11.50548,"median":-6.539234,"eighty":-3.357016,"marketCap":462404835},{"date":"2023-09-01","current":-1.59158,"twenty":-11.482698,"median":-6.41337,"eighty":-3.331929,"marketCap":526524972},{"date":"2023-09-08","current":-1.410804,"twenty":-11.472966,"median":-6.318181,"eighty":-3.324089,"marketCap":466720613},{"date":"2023-09-15","current":-1.263573,"twenty":-11.45451,"median":-6.233373,"eighty":-3.276697,"marketCap":418013970},{"date":"2023-09-22","current":-1.06416,"twenty":-11.42629,"median":-6.169448,"eighty":-3.258626,"marketCap":352044214},{"date":"2023-09-29","current":-1.032477,"twenty":-11.412962,"median":-6.063847,"eighty":-3.243339,"marketCap":341563038},{"date":"2023-10-06","current":-0.825609,"twenty":-11.409469,"median":-6.015605,"eighty":-3.209235,"marketCap":273127122},{"date":"2023-10-13","current":-0.723107,"twenty":-11.400642,"median":-5.976506,"eighty":-3.17241,"marketCap":239217434},{"date":"2023-10-20","current":-0.862364,"twenty":-11.394391,"median":-5.943853,"eighty":-3.144949,"marketCap":285286553},{"date":"2023-10-27","current":-0.674523,"twenty":-11.393302,"median":-5.897561,"eighty":-3.132013,"marketCap":223144927},{"date":"2023-11-03","current":-0.631831,"twenty":-11.3807,"median":-5.832752,"eighty":-3.102605,"marketCap":209021831},{"date":"2023-11-10","current":-0.704673,"twenty":-11.37157,"median":-5.807292,"eighty":-3.047735,"marketCap":188764148},{"date":"2023-11-17","current":-0.687056,"twenty":-11.346823,"median":-5.756372,"eighty":-2.919717,"marketCap":184045044},{"date":"2023-11-24","current":-0.715243,"twenty":-11.332581,"median":-5.74827,"eighty":-2.89004,"marketCap":191595610},{"date":"2023-12-01","current":-0.648299,"twenty":-11.314858,"median":-5.661473,"eighty":-2.85821,"marketCap":173663016},{"date":"2023-12-08","current":-0.77514,"twenty":-11.299109,"median":-5.61116,"eighty":-2.829879,"marketCap":207640562},{"date":"2023-12-15","current":-0.894934,"twenty":-11.293967,"median":-5.604262,"eighty":-2.79098,"marketCap":239730467},{"date":"2023-12-22","current":-0.916074,"twenty":-11.292281,"median":-5.578714,"eighty":-2.755309,"marketCap":245393392},{"date":"2023-12-29","current":-1.16271,"twenty":-11.289083,"median":-5.550718,"eighty":-2.739778,"marketCap":311460844},{"date":"2024-01-05","current":-1.423438,"twenty":-11.284722,"median":-5.517653,"eighty":-2.726645,"marketCap":381303578},{"date":"2024-01-12","current":-1.303644,"twenty":-11.275195,"median":-5.468205,"eighty":-2.710884,"marketCap":349213673},{"date":"2024-01-19","current":-1.15214,"twenty":-11.273957,"median":-5.410909,"eighty":-2.683375,"marketCap":308629381},{"date":"2024-01-26","current":-1.705307,"twenty":-11.26666,"median":-5.338123,"eighty":-2.63862,"marketCap":456809238},{"date":"2024-02-02","current":-2.339513,"twenty":-11.245892,"median":-5.316274,"eighty":-2.5217,"marketCap":626696971},{"date":"2024-02-09","current":-2.008317,"twenty":-11.235431,"median":-5.300252,"eighty":-2.355353,"marketCap":537977821},{"date":"2024-02-16","current":-2.80812,"twenty":-11.215339,"median":-5.274637,"eighty":-2.353607,"marketCap":752225129},{"date":"2024-02-23","current":-3.389475,"twenty":-11.193086,"median":-5.243958,"eighty":-2.35844,"marketCap":907955551},{"date":"2024-03-01","current":-4.415798,"twenty":-11.179221,"median":-5.210536,"eighty":-2.366373,"marketCap":1157557164},{"date":"2024-03-08","current":-4.552536,"twenty":-11.17772,"median":-5.178886,"eighty":-2.404028,"marketCap":1193401658},{"date":"2024-03-15","current":-4.798144,"twenty":-11.175512,"median":-5.16332,"eighty":-2.42907,"marketCap":1257785562},{"date":"2024-03-22","current":-4.464818,"twenty":-11.171802,"median":-5.11905,"eighty":-2.470406,"marketCap":1170407406},{"date":"2024-03-28","current":-4.206052,"twenty":-11.16566,"median":-5.109901,"eighty":-2.509149,"marketCap":1102574364},{"date":"2024-04-05","current":-4.714813,"twenty":-11.145495,"median":-5.075513,"eighty":-2.557002,"marketCap":1235941023},{"date":"2024-04-12","current":-5.210416,"twenty":-11.12515,"median":-5.095799,"eighty":-2.606851,"marketCap":1365858545},{"date":"2024-04-19","current":-4.144649,"twenty":-11.113923,"median":-5.07328,"eighty":-2.62341,"marketCap":1086478388},{"date":"2024-04-26","current":-3.767464,"twenty":-11.091906,"median":-5.05583,"eighty":-2.636335,"marketCap":987603106},{"date":"2024-05-03","current":-3.790016,"twenty":-11.081237,"median":-5.037413,"eighty":-2.643782,"marketCap":993514905},{"date":"2024-05-10","current":-3.534411,"twenty":-11.066745,"median":-5.030152,"eighty":-2.650615,"marketCap":926510411},{"date":"2024-05-17","current":-4.855853,"twenty":-11.046309,"median":-5.025142,"eighty":-2.659377,"marketCap":1055769175},{"date":"2024-05-24","current":-4.834555,"twenty":-11.036641,"median":-5.02201,"eighty":-2.673382,"marketCap":1051138609},{"date":"2024-05-31","current":-4.61093,"twenty":-11.024634,"median":-4.987567,"eighty":-2.678888,"marketCap":1002517660},{"date":"2024-06-07","current":-4.046544,"twenty":-11.021424,"median":-4.981441,"eighty":-2.688453,"marketCap":879807646},{"date":"2024-06-14","current":-4.972989,"twenty":-11.017566,"median":-4.975947,"eighty":-2.702782,"marketCap":1081237291},{"date":"2024-06-21","current":-4.408603,"twenty":-11.012758,"median":-4.972608,"eighty":-2.705918,"marketCap":958527277},{"date":"2024-06-28","current":-5.015585,"twenty":-11.011194,"median":-4.972608,"eighty":-2.707538,"marketCap":1090498424},{"date":"2024-07-05","current":-5.111424,"twenty":-11.009747,"median":-4.973284,"eighty":-2.710884,"marketCap":1111335974},{"date":"2024-07-12","current":-5.713081,"twenty":-11.006122,"median":-4.979583,"eighty":-2.718764,"marketCap":1242149479},{"date":"2024-07-15","current":-5.654513,"twenty":-11.000819,"median":-4.981441,"eighty":-2.719552,"marketCap":1229415421},{"date":"2024-08-02","current":-5.047531,"twenty":-10.995515,"median":-4.9833,"eighty":-2.72034,"marketCap":1097444274},{"date":"2024-08-09","current":-4.760013,"twenty":-10.97953,"median":-4.975947,"eighty":-2.723261,"marketCap":1034931626},{"date":"2024-08-16","current":-4.998786,"twenty":-10.978983,"median":-4.9833,"eighty":-2.725115,"marketCap":993573695},{"date":"2024-08-23","current":-4.892929,"twenty":-10.969611,"median":-4.981441,"eighty":-2.730428,"marketCap":972533311},{"date":"2024-08-30","current":-6.469017,"twenty":-10.956248,"median":-4.987567,"eighty":-2.737048,"marketCap":1285801253},{"date":"2024-09-06","current":-6.369041,"twenty":-10.955236,"median":-4.998786,"eighty":-2.739122,"marketCap":1265929779},{"date":"2024-09-13","current":-6.186733,"twenty":-10.952072,"median":-5.018797,"eighty":-2.744144,"marketCap":1229693561},{"date":"2024-09-20","current":-5.963258,"twenty":-10.943556,"median":-5.029203,"eighty":-2.754133,"marketCap":1185274973},{"date":"2024-09-27","current":-5.386927,"twenty":-10.911511,"median":-5.033257,"eighty":-2.758053,"marketCap":1070721770},{"date":"2024-10-04","current":-5.983841,"twenty":-10.864968,"median":-5.045026,"eighty":-2.769421,"marketCap":1189366159},{"date":"2024-10-11","current":-5.751544,"twenty":-10.844638,"median":-5.050193,"eighty":-2.778437,"marketCap":1143194204},{"date":"2024-10-18","current":-5.580998,"twenty":-10.823071,"median":-5.073125,"eighty":-2.785101,"marketCap":1109295808},{"date":"2024-10-25","current":-4.945858,"twenty":-10.815844,"median":-5.054343,"eighty":-2.79426,"marketCap":983053503},{"date":"2024-10-31","current":-5.010548,"twenty":-10.807502,"median":-5.054343,"eighty":-2.799539,"marketCap":995911515},{"date":"2024-11-08","current":-6.225299,"twenty":-10.761965,"median":-5.07328,"eighty":-2.80274,"marketCap":1217263746},{"date":"2024-11-15","current":-5.943963,"twenty":-10.754335,"median":-5.082373,"eighty":-2.80812,"marketCap":1162252788},{"date":"2024-11-22","current":-6.129525,"twenty":-10.74289,"median":-5.095799,"eighty":-2.80939,"marketCap":1198536611},{"date":"2024-11-29","current":-7.805567,"twenty":-10.739838,"median":-5.109901,"eighty":-2.829879,"marketCap":1526261466},{"date":"2024-12-06","current":-7.368599,"twenty":-10.732971,"median":-5.112171,"eighty":-2.837415,"marketCap":1440818915},{"date":"2024-12-13","current":-7.332683,"twenty":-10.704651,"median":-5.122285,"eighty":-2.848861,"marketCap":1433796239},{"date":"2024-12-20","current":-8.446054,"twenty":-10.694865,"median":-5.131241,"eighty":-2.8525,"marketCap":1651499179},{"date":"2024-12-27","current":-8.936895,"twenty":-10.693615,"median":-5.149828,"eighty":-2.85684,"marketCap":1747475743},{"date":"2025-01-03","current":-8.715418,"twenty":-10.687708,"median":-5.171392,"eighty":-2.863145,"marketCap":1704169244},{"date":"2025-01-10","current":-9.140414,"twenty":-10.673782,"median":-5.178886,"eighty":-2.869846,"marketCap":1787270904},{"date":"2025-01-17","current":-8.230563,"twenty":-10.648233,"median":-5.208632,"eighty":-2.877611,"marketCap":1609363126},{"date":"2025-01-24","current":-8.140775,"twenty":-10.63475,"median":-5.212441,"eighty":-2.887018,"marketCap":1591806437},{"date":"2025-01-31","current":-8.182676,"twenty":-10.582611,"median":-5.220449,"eighty":-2.889285,"marketCap":1599999558},{"date":"2025-02-07","current":-7.434443,"twenty":-10.512422,"median":-5.220449,"eighty":-2.889285,"marketCap":1453693820},{"date":"2025-02-14","current":-7.368599,"twenty":-10.415568,"median":-5.220449,"eighty":-2.889285,"marketCap":1440818915},{"date":"2025-02-21","current":-8.033029,"twenty":-10.387842,"median":-5.220449,"eighty":-2.889285,"marketCap":1570738411},{"date":"2025-02-28","current":-10.843904,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1518569408},{"date":"2025-03-07","current":-12.284109,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1720254407},{"date":"2025-03-14","current":-12.546735,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1757032260},{"date":"2025-03-21","current":-14.207208,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1989563200},{"date":"2025-03-28","current":-13.631126,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1908889201},{"date":"2025-04-04","current":-13.690428,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1917193877},{"date":"2025-04-11","current":-11.386099,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1594497878},{"date":"2025-04-17","current":-10.979452,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1537551525},{"date":"2025-04-25","current":-12.470489,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1746354819},{"date":"2025-05-02","current":-12.411186,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1738050142},{"date":"2025-05-09","current":-12.419431,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1611011299},{"date":"2025-05-16","current":-12.525108,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1624719498},{"date":"2025-05-23","current":-12.552677,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1628295549},{"date":"2025-05-30","current":-12.561866,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1629487567},{"date":"2025-06-06","current":-12.414836,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1610415291},{"date":"2025-06-13","current":-12.405647,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1609223274},{"date":"2025-06-20","current":-12.561866,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1629487567},{"date":"2025-06-27","current":-13.23269,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1716504825},{"date":"2025-07-03","current":-12.699706,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1647367825},{"date":"2025-07-11","current":-14.032165,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1820210325},{"date":"2025-07-18","current":-14.225142,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1845242687},{"date":"2025-07-25","current":-13.802431,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1790409894},{"date":"2025-08-01","current":-13.398098,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1737961135},{"date":"2025-08-08","current":-18.152048,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1693059701},{"date":"2025-08-15","current":-20.543182,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1916083146},{"date":"2025-08-22","current":-20.298927,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1893301181},{"date":"2025-08-29","current":-19.91326,"twenty":-10.381059,"median":-5.215051,"eighty":-2.887774,"marketCap":1857329658},{"date":"2025-09-05","current":-20.83886,"twenty":-10.384012,"median":-5.212441,"eighty":-2.887018,"marketCap":1943661314},{"date":"2025-09-12","current":-22.741483,"twenty":-10.420146,"median":-5.215051,"eighty":-2.887774,"marketCap":2121120829},{"date":"2025-09-19","current":-22.767194,"twenty":-10.423749,"median":-5.215051,"eighty":-2.887774,"marketCap":2123518931},{"date":"2025-09-26","current":-21.507349,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2006011954},{"date":"2025-10-03","current":-27.318061,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2547982907},{"date":"2025-10-10","current":-26.623861,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2483234165},{"date":"2025-10-17","current":-26.880972,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2507215180},{"date":"2025-10-24","current":-25.813961,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2407693966},{"date":"2025-10-31","current":-68.868004,"twenty":-10.690502,"median":-5.215051,"eighty":-2.887774,"marketCap":3052505424},{"date":"2025-11-07","current":-69.365446,"twenty":-10.752046,"median":-5.215051,"eighty":-2.887774,"marketCap":3074554019},{"date":"2025-11-14","current":-63.175063,"twenty":-10.869212,"median":-5.215051,"eighty":-2.887774,"marketCap":2800171509},{"date":"2025-11-21","current":-75.528193,"twenty":-10.975168,"median":-5.215051,"eighty":-2.887774,"marketCap":3347711607},{"date":"2025-11-28","current":-84.703224,"twenty":-11.010469,"median":-5.215051,"eighty":-2.887774,"marketCap":3754385684},{"date":"2025-12-05","current":-86.112641,"twenty":-11.07479,"median":-5.215051,"eighty":-2.887774,"marketCap":3816856702},{"date":"2025-12-12","current":-81.442219,"twenty":-11.173501,"median":-5.215051,"eighty":-2.887774,"marketCap":3609844898},{"date":"2025-12-19","current":-76.771796,"twenty":-11.177769,"median":-5.215051,"eighty":-2.887774,"marketCap":3402833093},{"date":"2025-12-26","current":-81.386947,"twenty":-11.196048,"median":-5.215051,"eighty":-2.887774,"marketCap":3607395054},{"date":"2026-01-02","current":-80.253886,"twenty":-11.282507,"median":-5.215051,"eighty":-2.887774,"marketCap":3557173255},{"date":"2026-01-09","current":-82.57528,"twenty":-11.378874,"median":-5.215051,"eighty":-2.887774,"marketCap":3660066696},{"date":"2026-01-16","current":-72.847536,"twenty":-11.521061,"median":-5.215051,"eighty":-2.887774,"marketCap":3228894181},{"date":"2026-01-23","current":-73.648969,"twenty":-11.696864,"median":-5.215051,"eighty":-2.887774,"marketCap":3264416916},{"date":"2026-01-30","current":-71.106491,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3151724100},{"date":"2026-02-06","current":-72.046102,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3193371445},{"date":"2026-02-13","current":-73.814783,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3271766448},{"date":"2026-02-20","current":-77.241602,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3423656766},{"date":"2026-02-27","current":-219.54239,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3543633723},{"date":"2026-03-06","current":-184.194298,"twenty":-12.014889,"median":-5.215051,"eighty":-2.887774,"marketCap":2973080166},{"date":"2026-03-13","current":-176.048868,"twenty":-12.184571,"median":-5.215051,"eighty":-2.887774,"marketCap":2841604781},{"date":"2026-03-20","current":-176.048868,"twenty":-12.300473,"median":-5.215051,"eighty":-2.887774,"marketCap":2841604781},{"date":"2026-03-27","current":-171.976153,"twenty":-12.370522,"median":-5.215051,"eighty":-2.887774,"marketCap":2775867089},{"date":"2026-04-02","current":-185.193266,"twenty":-12.401971,"median":-5.215051,"eighty":-2.887774,"marketCap":2989204506},{"date":"2026-04-10","current":-188.804919,"twenty":-12.463034,"median":-5.215051,"eighty":-2.887774,"marketCap":3047500195},{"date":"2026-04-17","current":-185.884859,"twenty":-12.497213,"median":-5.215051,"eighty":-2.887774,"marketCap":3000367510},{"date":"2026-04-24","current":-175.66465,"twenty":-12.560028,"median":-5.215051,"eighty":-2.887774,"marketCap":2835403112},{"date":"2026-05-01","current":-179.926946,"twenty":-12.630401,"median":-5.215051,"eighty":-2.887774,"marketCap":2904200841},{"date":"2026-05-08","current":-1087.547695,"twenty":-12.681519,"median":-5.215051,"eighty":-2.887774,"marketCap":2584013324},{"date":"2026-05-15","current":-1135.542246,"twenty":-12.751167,"median":-5.215051,"eighty":-2.887774,"marketCap":2698048377},{"date":"2026-05-22","current":-1106.061316,"twenty":-12.955163,"median":-5.215051,"eighty":-2.887774,"marketCap":2628001687},{"date":"2026-05-29","current":-1128.698459,"twenty":-13.116775,"median":-5.212441,"eighty":-2.887018,"marketCap":2681787538},{"date":"2026-06-05","current":-1155.547163,"twenty":-13.175716,"median":-5.215051,"eighty":-2.887774,"marketCap":2745580059},{"date":"2026-06-12","current":-1294.528689,"twenty":-13.246454,"median":-5.215051,"eighty":-2.887774,"marketCap":3075800166},{"date":"2026-06-18","current":-1380.339253,"twenty":-13.341124,"median":-5.215051,"eighty":-2.887774,"marketCap":3279686066},{"date":"2026-06-26","current":-1405.082177,"twenty":-13.453235,"median":-5.212441,"eighty":-2.887018,"marketCap":3338475252},{"date":"2026-07-02","current":-1360.334337,"twenty":-13.690428,"median":-5.212441,"eighty":-2.887018,"marketCap":3232154384},{"date":"2026-07-10","current":-1515.109218,"twenty":-13.802431,"median":-5.212441,"eighty":-2.887018,"marketCap":3599899503},{"date":"2026-07-17","current":-1460.35892,"twenty":-14.063187,"median":-5.212441,"eighty":-2.887018,"marketCap":3469812794},{"date":"2026-07-24","current":-1438.774668,"twenty":-14.225142,"median":-5.212441,"eighty":-2.887018,"marketCap":3418528611},{"date":"2026-07-31","current":-1473.52005,"twenty":-15.348603,"median":-5.211429,"eighty":-2.884666,"marketCap":3501083638},{"date":"2026-08-07","current":116.485099,"twenty":-18.956806,"median":-5.20219,"eighty":-2.86671,"marketCap":3322038529},{"date":"2026-08-14","current":113.840715,"twenty":-18.956806,"median":-5.161919,"eighty":-2.829879,"marketCap":3246623352},{"date":"2026-08-21","current":111.725208,"twenty":-18.956806,"median":-5.125225,"eighty":-2.79098,"marketCap":3186291211},{"date":"2026-08-28","current":109.609701,"twenty":-18.956806,"median":-5.110663,"eighty":-2.751342,"marketCap":3125959070},{"date":"2026-08-31","current":104.805738,"twenty":-18.956806,"median":-5.104331,"eighty":-2.741089,"marketCap":2988954832}],"updateTime":1788289652521},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARQT\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629215045","title":"Arcutis’ Zoryve® (Roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2629215045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629215045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:01","pubTimestamp":1776859318,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629686330","title":"Arcutis Biotherapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629686330","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629686330?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:39","pubTimestamp":1776803960,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics scheduled virtual annual stockholder meeting for June 5, 2026.Stockholders will vote to elect three Class III directors for terms running to 2029.Non-binding advisory vote set on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL9vM1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627890466","title":"Arcutis Biotherapeutics (ARQT) Gets a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2627890466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627890466?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:55","pubTimestamp":1776113734,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Arcutis Biotherapeutics today and set a price target of $35.00. Ear covers the Healthca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/arcutis-biotherapeutics-arqt-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/arcutis-biotherapeutics-arqt-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","ARQT","MFG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625952712","title":"Why Arcutis Biotherapeutics (ARQT) Is Up 10.9% After Positive Infant Atopic Dermatitis Trial Data And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2625952712","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625952712?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:18","pubTimestamp":1775575095,"startTime":"0","endTime":"0","summary":"At the 2026 American Academy of Dermatology meeting in Denver, Arcutis Biotherapeutics reported Phase 2 INTEGUMENT-INFANT data showing ZORYVE cream 0.05% improved signs and symptoms of mild to moderate atopic dermatitis in infants aged 3 to less than 24 months, with a safety and tolerability profile consistent with prior pediatric trials.\nBeyond reinforcing ZORYVE’s safety across very young patients, the new data underpin Arcutis’ plan to file a supplemental New Drug Application in 2026,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/why-arcutis-biotherapeutics-arqt-is-up-109-after-positive-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/why-arcutis-biotherapeutics-arqt-is-up-109-after-positive-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624662969","title":"Arcutis director Howard G. Welgus disposes of common shares worth $0.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624662969","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624662969?lang=en_us&edition=fundamental","pubTime":"2026-04-04 05:46","pubTimestamp":1775252812,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics director Howard G. Welgus sold 10,000 shares on April 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL7c13sY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcutis director Howard G. Welgus disposes of common shares worth $0.2 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624353747","title":"Arcutis management to present at Needham Virtual Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2624353747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624353747?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:11","pubTimestamp":1774987898,"startTime":"0","endTime":"0","summary":"Arcutis management will present at Needham Virtual Healthcare Conference on April 13-16, 2026.Fireside chat scheduled for April 14, 2026 at 11:00 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL72lgC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623460360","title":"How New Infant Atopic Dermatitis Data And sNDA Plans At Arcutis (ARQT) Have Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2623460360","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623460360?lang=en_us&edition=fundamental","pubTime":"2026-03-30 10:04","pubTimestamp":1774836297,"startTime":"0","endTime":"0","summary":"On March 28, 2026, Arcutis Biotherapeutics presented new INTEGUMENT-INFANT Phase 2 and other ZORYVE data at the American Academy of Dermatology meeting in Denver, highlighting reduced signs and symptoms of atopic dermatitis and favorable safety across infants and young children.\nThe company plans to use these infant trial results to support a supplemental New Drug Application for ZORYVE cream 0.05% in infants, potentially broadening its addressable patient population across age groups and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/how-new-infant-atopic-dermatitis-data-and-snda-plans-at-arcu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/how-new-infant-atopic-dermatitis-data-and-snda-plans-at-arcu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623418351","title":"Arcutis Biotherapeutics presents new Phase 2 results on Zoryve cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2623418351","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623418351?lang=en_us&edition=fundamental","pubTime":"2026-03-29 22:30","pubTimestamp":1774794641,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) announced new data from the Integument-Infant Phase 2 trial demonstrating that Zoryve cream 0.05% reduced signs and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-presents-new-phase-2-results-on-zoryve-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-presents-new-phase-2-results-on-zoryve-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828193","title":"Arcutis says Phase 2 trial shows Zoryve cream improves infant atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828193","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828193?lang=en_us&edition=fundamental","pubTime":"2026-03-28 23:00","pubTimestamp":1774710030,"startTime":"0","endTime":"0","summary":"Arcutis released new Phase 2 data from INTEGUMENT-INFANT showing investigational ZORYVE  cream 0.05% improved mild-to-moderate atopic dermatitis in infants aged 3 months to under 24 months over four weeks.Results were presented today in a late-breaking session at 2026 American Academy of Dermatology Annual Meeting.Among infants completing treatment, 34.4% met vIGA-AD success at Week 4, supporting efficacy in a population with limited topical options.Caregiver-reported itch improved quickly, with 46.6% reaching DPS-25 at 10 minutes, a potential differentiator for uptake in pediatric dermatology.Data package is slated to support a supplemental New Drug Application in Q2 2026 to expand ZORYVE cream 0.05% into infants as young as 3 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260328:nNDL9XwBgD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","ARQT","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","SG9999014021.USD","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620021441","title":"A Look At Arcutis Biotherapeutics (ARQT) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2620021441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620021441?lang=en_us&edition=fundamental","pubTime":"2026-03-19 14:08","pubTimestamp":1773900526,"startTime":"0","endTime":"0","summary":"Why Arcutis Biotherapeutics Stock Is On Investors’ Radar\nArcutis Biotherapeutics (ARQT) shares have drawn attention after a mixed stretch, with negative returns over the past week, month, and past 3 months, alongside a positive 1 year total return and a value score of 6.\nSee our latest analysis for Arcutis Biotherapeutics.\nThe recent 7 day share price return of a 7.14% decline and 30 day share price return of a 14% decline contrast with a 1 year total shareholder return of 33.98%. This...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/a-look-at-arcutis-biotherapeutics-arqt-valuation-after-recen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/a-look-at-arcutis-biotherapeutics-arqt-valuation-after-recen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620168255","title":"Arcutis Biotherapeutics to present clinical data on ZORYVE at AAD Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620168255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620168255?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:20","pubTimestamp":1773836435,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) will present new data from its clinical development program and marketed ZORYVE portfolio during the 2026 American A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-to-present-clinical-data-on-zoryve-at-aad-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-to-present-clinical-data-on-zoryve-at-aad-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620253355","title":"Arcutis to present new ZORYVE trial data at American Academy of Dermatology annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620253355","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620253355?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:04","pubTimestamp":1773835485,"startTime":"0","endTime":"0","summary":"Arcutis to present new ZORYVE trial data at American Academy of Dermatology annual meeting               Arcutis will present clinical data on its ZORYVE (roflumilast) portfolio at the 2026 American A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9X2cN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","BK4139","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","ARQT","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618955304","title":"Arcutis Biotherapeutics announces publication on Phase 3 study of Zoryve cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2618955304","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618955304?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:12","pubTimestamp":1773148328,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) announced that Pediatric Dermatology published data from the Phase 3 open-label extension study evaluating once-dail...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-announces-publication-on-phase-3-study-of-zoryve-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-biotherapeutics-announces-publication-on-phase-3-study-of-zoryve-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618953543","title":"Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data With Zoryve® (Roflumilast) Cream 0.05% for Treatment of Mild-to-Moderate Atopic Dermatitis in Children Ages 2–5 in Pediatric Dermatology","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618953543?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:00","pubTimestamp":1773147602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nTUA43SGLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618673385","title":"Arcutis Launches First-in-Human ARQ-234 Trial, Expanding Its Atopic Dermatitis Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673385","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618673385?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:30","pubTimestamp":1773073827,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics Inc ($ARQT) announced an update on their ongoing clinical study. The study “A Phase 1a/1b, Double-Blind, Randomized, Placeb...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arcutis-launches-first-in-human-arq-234-trial-expanding-its-atopic-dermatitis-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arcutis-launches-first-in-human-arq-234-trial-expanding-its-atopic-dermatitis-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","ARQ","BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618218456","title":"Jefferies Remains a Buy on Arcutis Biotherapeutics (ARQT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618218456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618218456?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:16","pubTimestamp":1773062189,"startTime":"0","endTime":"0","summary":"In a report released today, from Jefferies reiterated a Buy rating on Arcutis Biotherapeutics, with a price target of $35.00. In addition to Jeffer...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-arcutis-biotherapeutics-arqt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-arcutis-biotherapeutics-arqt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617523895","title":"Press Release: Arcutis Announces Promotion of Mas Matsuda to Executive Vice President and Chief Legal Officer to Support Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2617523895","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617523895?lang=en_us&edition=fundamental","pubTime":"2026-03-05 22:00","pubTimestamp":1772719200,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., March 05, 2026  -- Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the promotion of Mas Matsuda, JD, currently senior vice president and general counsel, to executive vice president, chief legal officer, and corporate secretary. Mr. Matsuda will continue to lead the Company's legal, compliance, and governance strategy in support of the continued growth of the Company, commercialization of the ZORYVE  portfolio, and protection of the Company's intellectual property, as well as any corporate transactions.\"I am thrilled to announce Mas' promotion,\" said Frank Watanabe, president and chief executive officer of Arcutis. \"Since joining Arcutis, Mas has been a trusted adviser and an instrumental leader, strengthening our legal and compliance foundation while supporting the successful development and growth of ZORYVE. As we highlighted in our recent fourth ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139","BK4232","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617982205","title":"Arcutis (ARQT) Earnings Call Signals Scaled Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2617982205","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617982205?lang=en_us&edition=fundamental","pubTime":"2026-03-05 08:18","pubTimestamp":1772669919,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics Inc (($ARQT)) has held its Q4 earnings call. Read on for the main highlights of the call. Arcutis Biotherapeutics Inc. stru...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arcutis-arqt-earnings-call-signals-scaled-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arcutis-arqt-earnings-call-signals-scaled-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617569444","title":"Arcutis Biotherapeutics Director Keith R Leonard Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617569444","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617569444?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:18","pubTimestamp":1772659094,"startTime":"0","endTime":"0","summary":"Keith R. Leonard, a Director of Arcutis Biotherapeutics, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLbTnH6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcutis Biotherapeutics Director Keith R Leonard Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616786328","title":"Arcutis first participant enrolled in Phase 1a/1b trial of ARQ-234-131","url":"https://stock-news.laohu8.com/highlight/detail?id=2616786328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616786328?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:17","pubTimestamp":1772543849,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT), announced that the first participant has been enrolled in a Phase 1a/1b, double-blind, randomized, placebo-controll...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-first-participant-enrolled-in-phase-1a-1b-trial-of-arq-234-131-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-first-participant-enrolled-in-phase-1a-1b-trial-of-arq-234-131-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4109","ARQT","ARQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":103,"code":"91000000","status":"200"}]}}